Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions.
- 1 January 2001
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 18 (5) , 622-631
- https://doi.org/10.1023/a:1011077109233
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*Clinical Pharmacology & Therapeutics, 1998
- In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.1997
- The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations.1996
- Coadministration of Itraconazole With Hypolipidemic Agents May Induce Rhabdomyolysis in Healthy IndividualsArchives of Dermatology, 1996
- Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazoleClinical Pharmacology & Therapeutics, 1994
- Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.1993
- Mechanism of the Cardiotoxic Actions of TerfenadineJAMA, 1993
- Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1993
- Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reactionXenobiotica, 1992
- Biotransformation of lovastatinArchives of Biochemistry and Biophysics, 1991